ALLERGAN HOLDINGS UNLIMITED COMPANY has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are KANDY THERAPEUTICS LTD, MINERVA NEUROSCIENCES INC and RESPIRATORIUS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | Hungary | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Canada | 1 | |
#8 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Costello Tim | 6 |
#2 | Ceulemans Jens Jozef | 5 |
#3 | Heyns Philip Erna H | 5 |
#4 | Jans Eugeen Maria Jozef | 5 |
#5 | Villani Frank J | 4 |
#6 | Anzalone Luigi | 4 |
#7 | Fegely Barry | 4 |
#8 | Feibush Penina | 4 |
#9 | Faherty Lia | 2 |
#10 | Luthra Parven Kumar | 2 |
Publication | Filing date | Title |
---|---|---|
CA3109557A1 | Polymorphs of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid | |
WO2018069770A1 | Methods of treatment using eluxadoline |